<DOC>
	<DOCNO>NCT00761631</DOCNO>
	<brief_summary>This open-label , multicenter study design evaluate safety , tolerability immunogenicity 13-valent pneumococcal conjugate vaccine healthy child age 15 month le 18 year .</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine ( 13vPnC ) Healthy Children Aged 15 Months 17 Years</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male female subject &gt; 15months &lt; 18years good health , available entire study period reachable phone , parents/legal guardian able willing complete study procedure , write documentation health professional showing prior vaccination Prevnar ( except group 4 ) . Group 4 : Negative urine pregnancy test female subject menstruate . Previous reaction contraindication pneumococcal vaccine vaccine relate component , bleed diathesis , receive blood transfusion blood related product , immune deficiency , congenital malformation . Group 4 : Previous vaccination Prevnar pneumococcal vaccine . Pregnant breastfeed adolescent female .</criteria>
	<gender>All</gender>
	<minimum_age>15 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>